
    
      We will by letters and telephone contact all patients (n=64) who fulfill the inclusion
      criteria for this study.

      The testing in the study (bronchial hyperreactivity, skin prick testing, serum IgE) is
      cross-sectional, but we retrospectively collect data from the last 10 years about the skin
      condition and medication for atopic diseases.
    
  